Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Stability01:53

RNA Stability

33.6K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.6K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

5.6K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
5.6K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variants.

mAbs·2026
Same author

Orally bioavailable CB<sub>2</sub> receptor agonists attenuate neuroinflammation and stabilize the blood-brain barrier.

Research square·2026
Same author

Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization.

Nature communications·2025
Same author

Accelerating compound synthesis in drug discovery: the role of digitalisation and automation.

RSC medicinal chemistry·2025
Same author

Correction to: ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Scaling Down for Big Impact: Streamlined High-throughput Recombinant Adeno-associated Virus Production.

Journal of visualized experiments : JoVE·2025

Related Experiment Video

Updated: Jul 11, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K

Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.

Anne-Gaëlle Reinhart1, Anja Osterwald2, Philippe Ringler3

  • 1Roche Pharma Research and Early Development, Therapeutic Modalities, pCMC, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel 4070, Switzerland.

Molecular Pharmaceutics
|November 17, 2023
PubMed
Summary

mRNA lipid nanoparticles (LNPs) can maintain activity without freezing for extended periods. This study found specific LNPs, like C12-200, retain functionality at room temperature, easing storage and transport challenges for mRNA technology.

Keywords:
EGFPLC-MSLNPanalyticselectron microscopymRNAshelf-lifestability

More Related Videos

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.1K

Related Experiment Videos

Last Updated: Jul 11, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.1K

Area of Science:

  • Nanotechnology
  • Biotechnology
  • Pharmaceutical Sciences

Background:

  • mRNA lipid nanoparticles (LNPs) are crucial for drug and vaccine delivery.
  • Current mRNA LNP formulations require frozen storage, posing logistical and cost challenges.
  • Developing stable, non-frozen storage conditions is essential for broader mRNA LNP applications.

Purpose of the Study:

  • To assess the stability and activity of mRNA LNPs under non-frozen storage conditions.
  • To identify mRNA LNP formulations that maintain functionality at ambient temperatures.
  • To understand the structure-activity relationships influencing LNP stability.

Main Methods:

  • Synthesized five structurally diverse mRNA LNPs using microfluidic technology with varying ionizable lipids (C12-200, CKK-E12, MC3, SM-102, lipid 23).
  • Evaluated shelf-life stability over 9 weeks at 2-8°C, 25°C, and 40°C using analytical techniques (hydrodynamic diameter, zeta potential, encapsulation efficiency, polydispersity).
  • Assessed in vitro activity via EGFP protein expression in HEK293 cells and analyzed LNP architecture using cryo-EM.

Main Results:

  • Most LNPs showed minimal changes in physical characteristics (size, charge, encapsulation) during non-frozen storage.
  • RiboGreen assays suggested consistent mRNA content, but in vitro activity varied significantly.
  • LNP 1 (C12-200) and LNP 4 (SM-102) showed high initial transfection efficiency.
  • LNP 1 (C12-200) maintained activity for 11 weeks at 2-8°C and 25°C.
  • LNP 4 (SM-102) retained activity at 2-8°C but declined at 25°C over 11 weeks.

Conclusions:

  • Specific mRNA LNP formulations, particularly those with C12-200 lipid, demonstrate potential for non-frozen storage and transport.
  • In vitro activity assays are crucial for assessing LNP functionality, as physical stability metrics can be misleading.
  • Understanding LNP architecture and structure-activity relationships is key to overcoming storage limitations and expanding mRNA LNP applications beyond vaccines.